Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25;10(5):899.
doi: 10.3390/jcm10050899.

Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study

Affiliations

Gender-Based Differences by Age Range in Patients Hospitalized with COVID-19: A Spanish Observational Cohort Study

Claudia Josa-Laorden et al. J Clin Med. .

Abstract

There is some evidence that male gender could have a negative impact on the prognosis and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of the present study was to compare the characteristics of coronavirus disease 2019 (COVID-19) between hospitalized men and women with confirmed SARS-CoV-2 infection. This multicenter, retrospective, observational study is based on the SEMI-COVID-19 Registry. We analyzed the differences between men and women for a wide variety of demographic, clinical, and treatment variables, and the sex distribution of the reported COVID-19 deaths, as well as intensive care unit (ICU) admission by age subgroups. This work analyzed 12,063 patients (56.8% men). The women in our study were older than the men, on average (67.9 vs. 65.7 years; p < 001). Bilateral condensation was more frequent among men than women (31.8% vs. 29.9%; p = 0.007). The men needed non-invasive and invasive mechanical ventilation more frequently (5.6% vs. 3.6%, p < 0.001, and 7.9% vs. 4.8%, p < 0.001, respectively). The most prevalent complication was acute respiratory distress syndrome, with severe cases in 19.9% of men (p < 0.001). In men, intensive care unit admission was more frequent (10% vs. 6.1%; p < 0.001) and the mortality rate was higher (23.1% vs. 18.9%; p < 0.001). Regarding mortality, the differences by gender were statistically significant in the age groups from 55 years to 89 years of age. A multivariate analysis showed that female sex was significantly and independently associated with a lower risk of mortality in our study. Male sex appears to be related to worse progress in COVID-19 patients and is an independent prognostic factor for mortality. In order to fully understand its prognostic impact, other factors associated with sex must be considered.

Keywords: COVID-19; SARS-CoV-2; Spain; coronavirus; gender differences.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient inclusion flowchart.
Figure 2
Figure 2
Mortality between the sexes according to age range.
Figure 3
Figure 3
Intensive Care Unit (ICU) admission by sex and age range.

Similar articles

Cited by

References

    1. Ambrosino I., Barbagelata E., Ortona E., Ruggieri A., Massiah G., Giannico O.V., Politi C., Moretti A.M. Gender differences in patients with COVID-19: A narrative review. Monaldi Arch. Chest Dis. 2020;90 doi: 10.4081/monaldi.2020.1389. - DOI - PubMed
    1. Jin J.-M., Bai P., He W., Wu F., Liu X.-F., Han D.-M., Liu S., Yang J.-K. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front. Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152. - DOI - PMC - PubMed
    1. World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 15 January 2021)];2020 Available online: https://covid19.who.int/
    1. Prasad A., Prasad M. SARS-CoV-2: The emergence of a viral pathogen causing havoc on human existence. J. Genet. 2020;99:1–4. doi: 10.1007/s12041-020-01205-x. - DOI - PMC - PubMed
    1. Klein S.L., Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol. Sex Differ. 2020;11:1–10. doi: 10.1186/s13293-020-00301-y. - DOI - PMC - PubMed